RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Cash and cash equivalents

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024607+7.01%
Dec 31, 2023568-11.78%
Dec 31, 2022643-38.94%
Dec 31, 20211,054+28.77%
Dec 31, 2020818+83.29%
Dec 31, 2019446-60.74%
Dec 31, 20181,137+157.55%
Dec 31, 2017442+367.20%
Dec 31, 201695+9.76%
Dec 31, 201586+19.92%
Dec 31, 201472+66.20%
Dec 31, 201343+433.33%
Dec 31, 20128+217.27%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)